Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineReferences
- Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region - United States, 2006-2015.MMWR Morb Mortal Wkly Rep. 2017; 66: 897-903
- Illicit drug use, illicit drug use disorders, and drug overdose deaths in metropolitan and nonmetropolitan areas - United States.MMWR Surveill Summ. 2017; 66: 1-12
- Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000-2010.Med Care. 2013; 51: 870-878
- The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013.Med Care. 2016; 54: 901-906
The Council of Economic Advisers. The underestimated cost of the opioid crisis. Report to the President, 2017. Available at: https://www.whitehouse.gov/sites/whitehouse.gov/files/images/The%20Underestimated%20Cost%20of%20the%20Opioid%20Crisis.pdf. Accessed June 5, 2018.
- Clinical risk factors for death after release from prison in Washington state: a nested case-control study.Addiction. 2016; 111: 499-510
- Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009.Ann Intern Med. 2013; 159: 592-600
- Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings.Clin J Pain. 2007; 23: 173-179
- High rates of inappropriate drug use in the chronic pain population.Popul Health Manag. 2009; 12: 185-190
- Opioid metabolism.Mayo Clin Proc. 2009; 84: 613-624
- Simultaneous, quantitative determination of opiates, amphetamines, cocaine and benzoylecgonine in oral fluid by liquid chromatography quadrupole-time-of-flight mass spectrometry.J Chromatogr B Analyt Technol Biomed Life Sci. 2002; 779: 321-330
- LC-atmospheric pressure chemical ionization-MS/MS analysis of multiple illicit drugs, methadone, and their metabolites in oral fluid following protein precipitation.Anal Chem. 2003; 75: 798-804
- Simultaneous assay of cocaine, heroin and metabolites in hair, plasma, saliva and urine by gas chromatography-mass spectrometry.J Chromatogr B Biomed Appl. 1994; 660: 279-290
- High prevalence of 6-acetylmorphine in morphine-positive oral fluid specimens.Forensic Sci Int. 2003; 133: 22-25
- Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid.J Anal Toxicol. 2007; 31: 424-433
- Opioid serum concentrations in patients with chronic pain.J Palliat Med. 2007; 10: 1253-1255
- Opioid blood levels in high dose, chronic pain patients.Pract Pain Manag. 2006; 6: 1-8
- Forensic drug testing for opiates. IV. Analytical sensitivity, specificity, and accuracy of commercial urine opiate immunoassays.J Anal Toxicol. 1992; 16: 72-78
- Sensitivity of an opiate immunoassay for detecting hydrocodone and hydromorphone in urine from a clinical population: analysis of subthreshold results.J Anal Toxicol. 2015; 39: 24-28
- Experience with a urine opiate screening and confirmation cutoff of 2000 ng/mL.J Anal Toxicol. 1999; 23: 549-551
- The pharmacokinetics of morphine and morphine glucuronides in kidney failure.Clin Pharmacol Ther. 1993; 54: 158-167
- Hydrophilic interaction LC-MS/MS analysis of opioids in urine: significance of glucuronide metabolites.Bioanalysis. 2011; 3: 2603-2612
- Improved detection of opioid use in chronic pain patients through monitoring of opioid glucuronides in urine.J Anal Toxicol. 2012; 36: 541-547
- Detection and quantification of codeine-6-glucuronide, hydromorphone-3-glucuronide, oxymorphone-3-glucuronide, morphine 3-glucuronide and morphine-6-glucuronide in human hair from opioid users by LC-MS-MS.J Anal Toxicol. 2018; 42: 115-125
- Development and validation of a Novel LC-MS/MS opioid confirmation assay: evaluation of beta-glucuronidase enzymes and sample cleanup methods.J Anal Toxicol. 2016; 40: 323-329
- Hydrolysis of conjugated metabolites of buprenorphine. I. The quantitative enzymatic hydrolysis of buprenorphine-3-beta-D-glucuronide in human urine.J Anal Toxicol. 2001; 25: 589-593
- Hydrolysis of conjugated metabolites of buprenorphine II. The quantitative enzymatic hydrolysis of norbuprenorphine-3-beta-D-glucuronide in human urine.J Anal Toxicol. 2005; 29: 570-573
- Ultra-high-pressure liquid chromatography (UHPLC) in method development.Trends Anal Chem. 2014; 63: 21-30
- A High-throughput HPLC-MS/MS assay for the detection, quantification and simultaneous structural confirmation of 136 drugs and metabolites in human urine.Ther Drug Monit. 2017; 39: 565-574
- LC-MS-sMRM method development and validation of different classes of pain panel drugs and analysis of clinical urine samples.Basic Clin Pharmacol Toxicol. 2017; ([Epub ahead of print])
- Quantitative, multidrug pain medication testing by liquid chromatography: tandem mass spectrometry (LC-MS/MS).Methods Mol Biol. 2016; 1383: 223-240
- Detection and quantification of tricyclic antidepressants and other psychoactive drugs in urine by HPLC/MS/MS for pain management compliance testing.J Clin Lab Anal. 2012; 26: 286-294
- LC-MS/MS extends the range of drug analysis in pain patients.Ther Drug Monit. 2009; 31: 746-748
- Lower cutoffs for LC-MS/MS urine drug testing indicates better patient compliance.Pain Physician. 2017; 20: E1107-E1113
- Dilute and shoot: analysis of drugs of abuse using selected reaction monitoring for quantification and full scan product ion spectra for identification.J Anal Toxicol. 2012; 36: 106-111
- A hybrid liquid chromatography-mass spectrometry strategy in a forensic laboratory for opioid, cocaine and amphetamine classes in human urine using a hybrid linear ion trap-triple quadrupole mass spectrometer.J Chromatogr A. 2010; 1217: 6857-6866
- Rapid screening for 67 drugs and metabolites in serum or plasma by accurate-mass LC-TOF-MS.J Anal Toxicol. 2012; 36: 477-486
- Urine drug testing of chronic pain patients. III. Normetabolites as biomarkers of synthetic opioid use.J Anal Toxicol. 2010; 34: 444-449
- Criteria for opiate identification using liquid chromatography linked to tandem mass spectrometry: problems in routine practice.Ann Clin Biochem. 2009; 46: 50-57
- Real-time 2D separation by LC x differential ion mobility hyphenated to mass spectrometry.Anal Bioanal Chem. 2012; 402: 2555-2564
- Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: influence of ionization type, sample preparation, and biofluid.J Am Soc Mass Spectrom. 2003; 14: 1290-1294
- Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses.J Chromatogr B Analyt Technol Biomed Life Sci. 2007; 852: 22-34
- Ion suppression; a critical review on causes, evaluation, prevention and applications.Talanta. 2013; 115: 104-122
- They don't know what they don't know: internal medicine residents' knowledge and confidence in urine drug test interpretation for patients with chronic pain.J Gen Intern Med. 2012; 27: 1521-1527
- Urine drug test interpretation: what do physicians know?.J Opioid Manag. 2007; 3: 80-86
- Physician identification of opioid diversion: a difficult diagnosis.J Opioid Manag. 2012; 8: 5-6
- Family physicians' proficiency in urine drug test interpretation.J Opioid Manag. 2007; 3: 333-337
- Drug testing of adolescents in ambulatory medicine: physician practices and knowledge.Arch Pediatr Adolesc Med. 2006; 160: 146-150
Article info
Publication history
Footnotes
Disclosure Statement: Nothing to disclose.